Assembly Biosciences (ASMB) Deferred Taxes (2016 - 2019)
Assembly Biosciences (ASMB) posted quarterly Deferred Taxes of -$767000.0 for Q4 2019, down 167.28% year-over-year from $1.1 million in Q4 2018, and down 5013.33% quarter-over-quarter from -$15000.0 in Q3 2019.
Assembly Biosciences (ASMB) Deferred Taxes (2016 - 2019) Analysis & Trends
Assembly Biosciences' Deferred Taxes history runs 4 years deep, the most recent figure standing at -$767000.0 for Q4 2019.
- In Q4 2019, Deferred Taxes fell 167.28% year-over-year to -$767000.0; the TTM figure through Sep 2020 stood at -$767000.0 (down 169.29% YoY), while the FY2021 annual figure was -$2.5 million, changed N/A from the prior year.
- Deferred Taxes for Q4 2019 stood at -$767000.0, down from -$15000.0 in the prior quarter.
- The five-year high for Deferred Taxes was $1.1 million in Q4 2018, with the low at -$9.0 million in Q4 2017.
- The 4-year median for Deferred Taxes is -$24500.0 (2018), against an average of -$934848.7.
- The sharpest annual moves came in 2017 and 2018: Deferred Taxes sank 1355.43% in 2017, then jumped 112.67% in 2018.
- Assembly Biosciences' Deferred Taxes stood at -$618000.0 in 2016, then tumbled by 1355.43% to -$9.0 million in 2017, then surged by 112.67% to $1.1 million in 2018, then slumped by 167.28% to -$767000.0 in 2019.
- Business Quant data shows ASMB's Deferred Taxes at -$767000.0 in Q4 2019, -$15000.0 in Q3 2019, and -$11000.0 in Q2 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -69.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 194.40 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -137,876.64 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 2.66 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Assembly Biosciences | 670.88 Mn | 350.52 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | -767,000.00 |
| Sep 30, 2019 | -15,000.00 |
| Jun 30, 2019 | -11,000.00 |
| Mar 31, 2019 | -7,000.00 |
| Dec 31, 2018 | 1.14 Mn |
| Sep 30, 2018 | -6,000.00 |
| Jun 30, 2018 | -34,000.00 |
| Dec 31, 2017 | -8.99 Mn |
| Sep 30, 2017 | -35,903.00 |
| Dec 31, 2016 | -618,000.00 |